Replies to post #376392 on Elite Pharmaceuticals Inc (ELTP)

[jour_trader]

Agreed. With the recent sale of Vigabatrin to chalk up another ANDA sale, investors are in the dark about what Elite will keep vs sell off. I can’t imagine they only spent $300K each on all ANDAs sold off in the past. It’s as if mgmt enjoys going in circles and wasting shareholder money, but I’m sure it’s all for the sake of gaining experience for Elite.